Author(s):
National experts point to key developments in rheumatology to watch in the coming year.
FDA Issues CRL to Avacincaptad Pegol sNDA for Geographic Atrophy
Future Landscape of BTK Inhibitors for CSU
AASM Updates Clinical Guidelines for Restless Legs Syndrome
Challenges With Current Treatment Options for CSU
Shortened Pegloticase Infusions Feasible for Uncontrolled Gout, Reduces Treatment Burden
Study Finds Chronic Psychological Stress Triggers Skin Aging